The company
Becton, Dickinson and Company
BDX · NYSE
Health CareMedical DevicesLeading
BDX stood above a rising 150-day average in 30 of the last 52 weekly readings, including each of the last 13 weeks. It is 18.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 13 in a row
- Industry in uptrend
- 29% -5 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $5.4M
- Officials’ trades on record
- 86
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 30 of 52 weeks.
21 Apr – 20 Oct
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
86 disclosed lines: House 65, Senate 8, executive 13; 37 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 31 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 16 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 12 Jun 2026filed 22 Aug 2026 |
| Thomas H. Kean, Jr. House: U.S. House ClerkNJ07 | sold | $1k–$15k | 21 May 2026filed 18 Jun 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 27 Mar 2026filed 21 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 25 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 17 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $250k–$500k | 17 Mar 2026filed 14 May 2026 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $15k–$50k | 17 Mar 2026filed 3 Apr 2026 |
| Arjun Mody Executive branch: Office of Government EthicsSocial Security Administration | sold | $1k–$15k | 30 Jan 2026filed 10 Apr 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 6 Jan 2026filed 14 May 2026 |
Insiders
Buy orders, 12 months0
Sale orders, 12 months21
Buyers · sellers0 · 5
| Who | Did | Shares | Traded |
|---|---|---|---|
| Michael FeldEVP, Chief Revenue Officer | sold | 76at $183.70 | 28 Sep 2026filed 29 Sep 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 165at $188.49 | 26 Aug 2026filed 27 Aug 2026 |
| Thomas E. Polen, Jr.Chairman, CEO and President | sold | 4,152at $185.00 | 13 Aug 2026filed 14 Aug 2026 |
| Roland GoetteEVP and President, EMEA | sold | 2,438at $180.84 | 11 Aug 2026filed 12 Aug 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 75at $157.13 | 27 Jul 2026filed 28 Jul 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 75at $152.80 | 26 Jun 2026filed 26 Jun 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | sold | 1,100at $145.66 | 24 Jun 2026filed 25 Jun 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | sold | 1,100at $151.48 | 10 Jun 2026filed 11 Jun 2026 |
| Thomas E. Polen, Jr.Chairman, CEO and President | sold | 2,764at $146.35 | 1 Jun 2026filed 3 Jun 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 75at $147.35 | 26 May 2026filed 27 May 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 74at $151.94 | 27 Apr 2026filed 28 Apr 2026 |
| Michael FeldEVP, Chief Revenue Officer | sold | 75at $156.83 | 26 Mar 2026filed 27 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Becton, Dickinson and Company Yields 2.4%: Is Its Valuation Finally Worth a Look?insidermonkey.com · 14 Oct 2026Becton Dickinson (BDX) Grew Revenue 5.4% While Earnings Fell 34.3%. Why Did Profit Fall So Much Further?insidermonkey.com · 13 Oct 2026Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focusseekingalpha.com · 11 Oct 2026Becton Dickinson to Invest $19 Billion in US Manufacturingtheepochtimes.com · 7 Oct 2026Becton, Dickinson Partners With U.S. Govt. To Expand Domestic Manufacturing, To Invest $19 Blnfinanzen.ch · 6 Oct 2026Trump says Becton Dickinson to invest $3 billion to expand US medical product manufacturing – KSEV Radioksevradio.com · 6 Oct 2026BDX - Becton Dickinson & Co Analysismorningstar.com · 16 Sep 2026
Everyone who traded it
Same industry
Government contracts
Awards61
Total$158.1M
Latest2 Feb 2027
BRAND NAME OR EQUAL FLOW CYTOMETRY REAGENTSDepartment of Veterans Affairs · $363K · 1 Oct 2026FLOW CYTOMETRY REAGENT AND SUPPLIESDepartment of Veterans Affairs · $311K · 1 Oct 2026MRSA TEST KITSDepartment of Veterans Affairs · $308K · 1 Oct 2026AUTOMATED FLOW CYTOMETRY TESTING SYSTEMDepartment of Veterans Affairs · $87K · 1 Oct 2026
From its SEC filings
Analyst forecasts
No analyst forecasts yet.